Doctor visits by pharmaceutical company representatives are being stopped!


Published: 04:51 5 May 2025
Pharmaceutical company sales representatives are losing the opportunity to communicate directly with doctors. From now on, they will no longer be able to visit hospitals or clinics to meet doctors and promote medicines. They will have to send information about medicines via e-mail. This proposal has been included in today's report of the commission formed to reform the health sector.
The Health Sector Reform Commission submitted its final report to the Chief Advisor at 11 am on Monday (May 5). The report highlights several groundbreaking proposals to make the country's healthcare sector more transparent, impartial and modern.
One of the most discussed proposals is to prevent the influence of pharmaceutical companies on doctors' professional decision-making. In this regard, the recommendation to stop sales representatives from visiting hospitals or clinics directly has gained special importance.
In addition, the commission has proposed the formulation of 7 new laws, including:
Bangladesh Health Commission Act
Bangladesh Health Service Act
Primary Health Service Act
Health Protection Act
Drug Pricing and Access Act
Allied Health Professionals Commissioner Act
Bangladesh Medical Research Commissioner Act
The commission was formed on November 17 last year, headed by Professor AK Azad Khan, President of Bangladesh Diabetic Association. The 12-member commission includes renowned physicians, administrators and researchers in the country's health sector.
The members of the commission are:
Professor Dr. Mohammad Zakir Hossain, Professor Dr. Liaquat Ali, Professor Dr. Saeba Akhter, Professor Dr. Naila Zaman Khan, former Secretary SM Reza, Professor Dr. Mozaherul Haque, Dr. Azharul Islam Khan, Professor Dr. Syed Md. Akram Hossain, Professor Dr. Syed Atiqul Haque, Dr. Ahmed Ehsanur Rahman and Umair Afif, a fifth-year student of Dhaka Medical College.
According to the commission, these recommendations have been made to ensure proper treatment of patients by reducing irregularities, conflicts of interest and commercial influence in the health sector.
- ACI to recruit manpower for officer posts, applications open until June 26
- Actor James was stabbed to death at the age of 81 by his girlfriend's son
- Freelancing income withheld at source, decision to refund previously deducted money
- I have created my own legacy in football, my name has been written in history: Neymar
- Jamaat leader faces criticism despite apology after controversial remarks about government
- US strikes Iran's coastal radar facility, tensions in the Middle East intensify
- BGB foils 8 push-ins at border in 24 hours
- Mentally challenged girl raped in Faridpur on the pretext of feeding her mango
- Initiative to reopen closed factories: Loans of up to 200 crore at 7% interest
- Turkey proposes joint drone factory in Bangladesh, new prospects in defense cooperation
- Khorshed Alam stands by fire-affected traders, provides financial assistance
- Expatriate wife disappears with lover, taking child, money and jewellery
- Missing BNP leaders Ilyas Ali, Dinar and 38 others acquitted after 15 years
- MPs' children should be made compulsory to attend local schools
- Mother: The refuge of selfless love
- ECNEC approves Tk 35,000 crore Padma Barrage project
- Jamaat Ameer visits July revolution fighters undergoing treatment in Bangkok hospital
- High Court takes a tough stance on gender identification, orders creation of central database within 6 months
- Seats of 4 students cancelled in government medical college, stir over allegations
- US Navy Strikes Suspected Drug Trafficking Vessel in Pacific Ocean, Kills 2
